37 matches found.
Malignancy, immuno- suppression, Metoject®, Methotrexate pre-filled syringe, RED, 10>1>3, Click here
URL: /elmmb-formulary/joint-medicines-formulary/index-search/?EntryId14=14383
Malignant disease, rheumatic disease, UNLICENSED SPECIAL, Methotrexate liquid, RED, Appendix 6, Once weekly dosing, Click here
URL: /elmmb-formulary/joint-medicines-formulary/index-search/?EntryId14=14004
Methotrexate 10mg tablets, Malignancy, Non-proprietary, RED, 8>1>3, Click here
URL: /elmmb-formulary/joint-medicines-formulary/index-search/?EntryId14=14183
Click here, Black traffic light, BLACK, Golimumab, Simponi®, Methotrexate naive patients with Rheumatoid Arthritis (NICE TA224)
URL: /elmmb-formulary/joint-medicines-formulary/index-search/?EntryId14=14322
Click here, Red for 10mg tabs & injection, 8>1>3, AMBER shared care, Non-proprietary, Malignancy, immuno- suppression, Methotrexate 2.5mg tablets
URL: /elmmb-formulary/joint-medicines-formulary/index-search/?EntryId14=13873
10.1.3 Drugs which suppress the rheumatic disease process
Last Modified: 01/02/2022
10.0 Musculoskeletal and joint diseases
Last Modified: 02/02/2022
Black Traffic Light Drugs (Not Recommended for Use)
Last Modified: 05/09/2022
Appendix 6 - Medicines not classified in the BNF – Imported or Unlicensed Products
Last Modified: 24/09/2021
NPSA Methotrexate Patient Briefing.pdf
Last Modified: 21/06/2016
Last Modified: 26/05/2016
